CAUSE WE'RE NOT GETTING ANY YOUNGER
Live / Applied — Final refusal mailed (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 12 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98747318
- Mark type
- Stylized text
- Filed
- 12 Sept 2024
- Attorney of record
- Jared L. DuJack
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics in the nature of improving longevity and treating age-related conditions; Biological research and analysis namely, biologic age scoring; Biological research and analysis, namely, statistical scoring to determine a biologic age score of a patient; Laboratory services; Laboratory services related to biologic age; Laboratory services related to biological age scoring; Laboratory services related to determining a number or percentage of senescent cells
- Class 044 — Medical, beauty and agricultural services: Anti-aging therapy in the nature of treatment of age-related conditions; Anti-aging services, namely treatment of age-related conditions; Anti-aging therapy in the nature of treatment to improve longevity; Medical services; Medical services, namely, anti-aging services in the nature of treatment of age-related condition; Medical services, namely, treatment of age-related disorders; Medical services in the nature of treatment to improve longevity; Medical research services; Medical research services, in the field of anti-aging; Medical research services in the nature of treatment of age-related disorders; Medical advisory services; Medical advisory services in the field of anti-aging; Medical advisory services in the field of prevention and treatment of age-related disorders; Medical testing services; Medical testing services in the field of anti-aging; Medical testing services in the field of prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services in the nature of performing biopsies in the field of senescent cells; Medical testing services in the nature of performing biopsies in the field of disorders related to biologic age; Medical testing services in the nature of performing biopsies in the field of biological age scoring; Medical testing services in the nature of performing biopsies in the field of related to determining a number or percentage of senescent cells; Non-invasive medical testing; Non-invasive medical testing related to biologic age; Non-invasive medical testing related to biological age scoring; Non-invasive medical testing related to determining a number or percentage of senescent cells
Owner
- Senotherapeutix, Inc., Surfside, FL, US
Prosecution history
- 04 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 04 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 04 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Nov 2025 — FINAL REFUSAL E-MAILED
- 04 Nov 2025 — FINAL REFUSAL WRITTEN
- 08 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 25 Jun 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN
- 21 Mar 2025 — ASSIGNED TO EXAMINER